Methods of achieving antileukemia activity using 16-membered...

Details Methods of achieving antileukemia activity using 16-membered... Methods of achieving antileukemia activity using 16-membered...

A - Human Necessities

61

K

A61K 31/35 (2006.01) A61K 31/335 (2006.01) A61K 31/365 (2006.01) A61K 31/71 (1990.01)

Patent

CA 2132310

2132310 9318653 PCTABS00025 Inhibition of renal cancer, melanoma, colon cancer, lung cancer and leukemia cells by administration of compounds from the bafilomycin and hygrolidin groups of compounds.

Affiliated with

Also associated with

Rating

Methods of achieving antileukemia activity using 16-membered... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of achieving antileukemia activity using 16-membered..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of achieving antileukemia activity using 16-membered... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1460279